Artwork

Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Eden Research CEO says new regulatory approval expands Spanish market for key biofungicide

5:01
 
Share
 

Manage episode 425711215 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Eden Research PLC CEO Sean Smith talked with Proactive about Spain's recent approval of Mevalone (known as Araw in Spain) for a wider range of crops and fungal pathogens. This significant regulatory authorisation is a pivotal development for the company, enabling it to expand its addressable market. "It's fantastic news," Smith said. "This is long-awaited news, and as folks that follow our story will recognise, regulatory authorisation is all important to us in terms of growing our addressable market. So, it's most welcome news." Smith explained that when Mevalone was launched in Spain in 2016, it was initially targeted at one fungal pathogen on grapes. Over the years, Eden Research has worked to expand its market to include a variety of horticultural crops such as berries, lettuce, cucumbers, squash, and tomatoes. The recent approval now covers additional fungal diseases, including powdery mildew and rust, which affect multiple crops. "We're getting very close to covering almost everything," Smith mentioned. He highlighted the inclusion of almonds, which are a significant crop in Spain, representing a substantial opportunity for Eden Research. The CEO also noted that this regulatory success in Spain could pave the way for further approvals in other countries, contributing to the company’s growth. Financial benefits from these developments are expected to start in earnest in 2025, with an anticipated 20-25% year-over-year growth from this label extension. Smith expressed optimism about the future growth fueled by these regulatory advancements. For more details on this and other updates from Eden Research, be sure to watch the full interview. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #EdenResearch #MevaloneApproval #AgricultureInnovation #FungalPathogens #CropProtection #RegulatoryApproval #Agribusiness #Horticulture #SustainableFarming #ProactiveInterviews #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
  continue reading

609 episodes

Artwork
iconShare
 
Manage episode 425711215 series 2891889
Content provided by Proactive Investors. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Proactive Investors or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Eden Research PLC CEO Sean Smith talked with Proactive about Spain's recent approval of Mevalone (known as Araw in Spain) for a wider range of crops and fungal pathogens. This significant regulatory authorisation is a pivotal development for the company, enabling it to expand its addressable market. "It's fantastic news," Smith said. "This is long-awaited news, and as folks that follow our story will recognise, regulatory authorisation is all important to us in terms of growing our addressable market. So, it's most welcome news." Smith explained that when Mevalone was launched in Spain in 2016, it was initially targeted at one fungal pathogen on grapes. Over the years, Eden Research has worked to expand its market to include a variety of horticultural crops such as berries, lettuce, cucumbers, squash, and tomatoes. The recent approval now covers additional fungal diseases, including powdery mildew and rust, which affect multiple crops. "We're getting very close to covering almost everything," Smith mentioned. He highlighted the inclusion of almonds, which are a significant crop in Spain, representing a substantial opportunity for Eden Research. The CEO also noted that this regulatory success in Spain could pave the way for further approvals in other countries, contributing to the company’s growth. Financial benefits from these developments are expected to start in earnest in 2025, with an anticipated 20-25% year-over-year growth from this label extension. Smith expressed optimism about the future growth fueled by these regulatory advancements. For more details on this and other updates from Eden Research, be sure to watch the full interview. Visit Proactive's YouTube channel for more videos, and don't forget to give the video a like, subscribe to the channel, and enable notifications for future content. #EdenResearch #MevaloneApproval #AgricultureInnovation #FungalPathogens #CropProtection #RegulatoryApproval #Agribusiness #Horticulture #SustainableFarming #ProactiveInterviews #ProactiveInvestors #invest #investing #investment #investor #stockmarket #stocks #stock #stockmarketnews
  continue reading

609 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide